In vitro evaluations demonstrate enhanced osteogenic activity and antibacterial properties of bioactive glass nanoparticles for bone repair, suggesting potential use in grafts.
Mesoporous bioactive glass nanoparticles (MBGNs) are promising for bone tissue engineering; however, surgical site infection and oxidative stress often compromise regeneration. To address this, MBGNs co-doped with cerium (Ce), zinc (Zn), and strontium (Sr) were synthesized using a microemulsion-assisted sol-gel route (xCe-yZn-Sr-MBGNs; x = 0, 1, 2; y = 0, 0.5, 1). The resulting spherical nanoparticles (150–200 nm) exhibited a mesoporous structure with a specific surface area of (~340–425 m2/g), sustained ion release, and apatite formation in simulated body fluid. In vitro evaluations with MC3T3-E1 pre-osteoblasts demonstrated dose-dependent cytocompatibility, specifically in the co-doped formulations; however, higher Ce concentrations (2Ce-yZn-Sr-MBGNs) reduced viability following prolonged exposure. Crucially, the 1Ce-1Zn-Sr-MBGNs significantly enhanced osteogenic differentiation, as evidenced by a two-fold increase in osteogenic marker gene expression and a ~45% increase in calcium mineral deposition compared to undoped MBGNs within 14 days. Moreover, these particles accelerated cell migration, achieving ~70% scratch-wound closure within 24 h. Furthermore, 1Ce-1Zn-Sr-MBGNs displayed strong radical scavenging capacity and potent antibacterial activity against S. aureus and P. aeruginosa. These findings indicated that 1Ce-1Zn-Sr-MBGNs exhibited multiple therapeutic effects, including antibacterial, radical-scavenging, and osteogenic effects. By optimizing dopant ratios, these multifunctional nanomaterials emerge as promising candidates for next-generation bone grafts or implant coatings. Within the scope of this study, they demonstrated the capacity to simultaneously address three critical challenges in bone healing: controlling infection, mitigating oxidative stress, and promoting mineralized tissue formation. While these in vitro results provide a robust foundation, further in vivo validation is warranted to confirm their efficacy within complex physiological environments.
No takes yet. Share an insight, caveat, or question.
Sae-sue et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: